cipla semaglutide strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy. This milestone launch is based on the recent ANDA approval obtained by Cipla's partner, Orbicular. Cipla Cipla strengthens US portfolio with
Description
Total Cholesterol
Feeling overwhelmed by the noise around GLP-1 medications like Ozempic
Tirzepatide injection timing matters for consistent blood levels and side effect management
Learn why resistance training is essential for protecting strength, mobility, and long-term health on GLP-1 medications.
Explore the dual nature of GLP-1 receptor agonists in colorectal cancer
Is Wegovy causing vision problems
